FATE THERAPEUTICS INC Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Fate Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • Fate Therapeutics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$52.4M, a 2.14% decline year-over-year.
  • Fate Therapeutics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$197M, a 4.96% increase year-over-year.
  • Fate Therapeutics Inc annual Operating Income (Loss) for 2023 was -$191M, a 38.2% increase from 2022.
  • Fate Therapeutics Inc annual Operating Income (Loss) for 2022 was -$308M, a 42.1% decline from 2021.
  • Fate Therapeutics Inc annual Operating Income (Loss) for 2021 was -$217M, a 69.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$191M +$118M +38.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 -$308M -$91.4M -42.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$217M -$88.9M -69.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 -$128M -$27.4M -27.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$101M -$33.6M -50.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$67.1M -$25M -59.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 -$42.1M -$10.2M -31.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$32M -$4.18M -15% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
2015 -$27.8M -$2.88M -11.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
2014 -$24.9M -$7.23M -40.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$17.7M -$4.12M -30.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-03
2012 -$13.6M -$264K -1.99% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 -$13.3M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.